Your browser doesn't support javascript.
loading
BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors.
Doxie, Deon B; Greenplate, Allison R; Gandelman, Jocelyn S; Diggins, Kirsten E; Roe, Caroline E; Dahlman, Kimberly B; Sosman, Jeffrey A; Kelley, Mark C; Irish, Jonathan M.
Afiliação
  • Doxie DB; Department of Cell and Developmental Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee.
  • Greenplate AR; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Gandelman JS; Department of Cell and Developmental Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee.
  • Diggins KE; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Roe CE; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Dahlman KB; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Sosman JA; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Kelley MC; Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Irish JM; Department of Cell and Developmental Biology, School of Medicine, Vanderbilt University, Nashville, Tennessee.
Pigment Cell Melanoma Res ; 31(6): 708-719, 2018 11.
Article em En | MEDLINE | ID: mdl-29778085

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article